Novocure
NVCR
#4729
Rank
$1.29 B
Marketcap
Jersey
Country
$12.05
Share price
-3.29%
Change (1 day)
-81.26%
Change (1 year)
Categories
Earnings for Novocure (NVCR)
Earnings in 2023 (TTM): -$0.19 B
According to Novocure 's latest financial reports the company's current earnings (TTM) are -$0.19 B. In 2022 the company made an earning of -$78.52 M a decrease over its 2021 earnings that were of -$48.64 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Novocure from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.19 B | 139.99% |
| 2022 | -$78.52 M | 61.43% |
| 2021 | -$48.64 M | -255.64% |
| 2020 | $31.24 M | 538.52% |
| 2019 | $4.89 M | -115.08% |
| 2018 | -$32.46 M | -15.13% |
| 2017 | -$38.24 M | -66.9% |
| 2016 | -$0.12 B | 10.26% |
| 2015 | -$0.11 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | -89.87% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | -61.22% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 180.55% | 🇺🇸 USA |
 Novocure
NVCR | -$0.19 B | 0.00% | Jersey |